Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Working Capital/Sales

    Back to All Ratios
PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 8.177.075.45

What is the latest Working Capital/Sales ratio of PIRAMAL PHARMA ?

The latest Working Capital/Sales ratio of PIRAMAL PHARMA is 8.17 based on Mar2023 Consolidated results.
Year Working Capital/Sales
Mar20238.17
Mar20227.07
Mar20215.45

How is Working Capital/Sales of PIRAMAL PHARMA Trending?

Years Working Capital/Sales % Change
Mar2023 8.17
15.56
Mar2022 7.07
29.72
Mar2021 5.45 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Working Capital/Sales ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹19,836.9 Cr 2% 5.4% 107.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹351,467.0 Cr -4.9% -2.6% 54% Stock Analytics
CIPLA ₹119,470.0 Cr -0.1% 5% 57.6% Stock Analytics
DIVIS LABORATORIES ₹116,563.0 Cr 8.1% 9.1% 25.6% Stock Analytics
ZYDUS LIFESCIENCES ₹105,690.0 Cr -2.4% 10.8% 110% Stock Analytics
DR REDDYS LABORATORIES ₹99,351.1 Cr 1.4% -4.8% 30.2% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

2%

5.4%

107.1%

SENSEX

1.7%

1.1%

21.3%


You may also like the below Video Courses